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Smoke-free legislation and child health
Timor Faber1,2, Jasper V Been1,3,4, Irwin K Reiss1, Johan P Mackenbach2 and Aziz Sheikh3,4,5,6
In this paper, we aim to present an overview of the scientific literature on the link between smoke-free legislation and early-life
health outcomes. Exposure to second-hand smoke is responsible for an estimated 166 ,000 child deaths each year worldwide. To
protect people from tobacco smoke, the World Health Organization recommends the implementation of comprehensive smoke-
free legislation that prohibits smoking in all public indoor spaces, including workplaces, bars and restaurants. The implementation
of such legislation has been found to reduce tobacco smoke exposure, encourage people to quit smoking and improve adult health
outcomes. There is an increasing body of evidence that shows that children also experience health benefits after implementation of
smoke-free legislation. In addition to protecting children from tobacco smoke in public, the link between smoke-free legislation and
improved child health is likely to be mediated via a decline in smoking during pregnancy and reduced exposure in the home
environment. Recent studies have found that the implementation of smoke-free legislation is associated with a substantial decrease
in the number of perinatal deaths, preterm births and hospital attendance for respiratory tract infections and asthma in children,
although such benefits are not found in each study. With over 80% of the world’s population currently unprotected by
comprehensive smoke-free laws, protecting (unborn) children from the adverse impact of tobacco smoking and SHS exposure
holds great potential to benefit public health and should therefore be a key priority for policymakers and health workers alike.
npj Primary Care Respiratory Medicine (2016) 26, 16067; doi:10.1038/npjpcrm.2016.67; published online 17 November 2016
INTRODUCTION
Despite the fact that the adverse health effects of tobacco
smoking were officially recognised over 50 years ago, smoking
continues to be the leading cause of preventable death
worldwide.1 Globally, over one billion people are regular
smokers, and annually an estimated six million people die as a
consequence of smoking.2 The prevalence of smoking is highest in
the reproductive age range, and approximately 10–20% of
women in high-income countries smoke throughout pregnancy.3
Smoking during pregnancy causes long-lasting epigenetic
changes,4 increases the risk for adverse health outcomes during
fetal life and childhood1 and may have long-term consequences in
later life, even for subsequent generations.5
Besides active smoking, exposure to second-hand smoke (SHS)
is responsible for an estimated 600,000 deaths and almost
11 million disability-adjusted life-years per year worldwide.6
Maternal SHS exposure during pregnancy is associated with
increased risks for stillbirth, low birthweight and paediatric
asthma.1,7–10 After birth, an estimated 40–50% of the world’s
children are regularly exposed to SHS, primarily by being around
smoking parents and/or other household members.6,11 As a result,
children make up over a quarter of all deaths and over half of all
disability-adjusted life-years associated with SHS exposure.6
These estimates are based on the impact of SHS on respiratory
tract infections (RTIs) and asthma only, and the estimated
burden of death and disease is likely much larger when in
addition considering other SHS-associated outcomes including
adverse perinatal outcomes, sudden infant death syndrome (SIDS)
and invasive meningococcal infections.6,12–14
To avoid this preventable burden of death and disease from
smoking and exposure to SHS, the World Health Organization
(WHO) established the international FCTC (Framework
Convention on Tobacco Control) in 2005.2 Having been ratified
by 180 countries, this treaty currently covers more than 90%
of the world’s population.15 To support participating countries
in implementing the agreements within the FCTC, the WHO
introduced a set of six policy measures in 2008 (represented
by the MPOWER acronym—Figure 1).2 As part of the MPOWER
measures, the WHO urges all countries to protect their people
from exposure to SHS by introducing comprehensive smoke-free
legislation to prohibit smoking in all indoor public spaces,
including workplaces.2 Besides reductions in SHS exposure,
smoke-free laws have also been associated with decreases in
smoking prevalence and in young people taking up smoking.16,17
There is also consistent evidence for an association between
smoke-free legislation and reductions in hospital admissions
and deaths owing to tobacco-associated cardiovascular and
respiratory diseases among adults.18,19 As developing humans,
children are particularly vulnerable to tobacco smoke and
generally cannot control their own exposure to tobacco
smoke. It is therefore important to consider the potential benefits
of smoke-free legislation to child health via reducing both
antenatal and postnatal SHS exposure.
AIM
The aim of this paper is to present an overview of the scientific
literature on the link between smoke-free legislation and perinatal
and paediatric health outcomes.
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IDENTIFICATION OF PAPERS
We performed a semi-structured search in PubMed to identify
recently published studies from 2005 up to June 2016, using the
following search equation: ‘(smok* OR tobacco OR cigar*)
AND (legislation* OR policy OR policies OR ban OR bans OR law
OR laws) AND (fetus OR fetal OR stillbirth OR newborn OR neonatal
OR baby OR babies OR infant OR child)'. We searched for
studies that examined the association between the introduction of
smoke-free legislation and health-related outcomes among
(unborn) children.
STUDYING THE LINK BETWEEN SMOKE-FREE LEGISLATION
AND CHILD HEALTH
A randomised controlled trial is generally considered the optimal
design to study the effectiveness of health interventions. National
public health policies such as the implementation of smoke-free
legislation are, however, generally not amendable to being
implemented in a randomised fashion. In such situations, it is
therefore necessary to consider alternative options to make causal
inferences regarding the relationship between an intervention
and health outcomes.20,21
Quasi-experimental studies, such as controlled before–after
studies and interrupted time series studies, can provide a robust
alternative to randomised controlled trials in such situations and
have been used to assess the potential population health benefits
of smoke-free legislation.22 Assessing causality from such studies
is, however, difficult owing to the inherent risk of bias and
confounding. Studies should therefore be carefully designed, and
in attempting to make causal inferences, it is (among other things)
important to develop logic models of how the intervention might
work and what process measures might help to shed light on the
mechanisms of action, the effect size and consistency of the
evidence.23
SMOKE-FREE LEGISLATION AND CHILD HEALTH: LIKELY
CAUSAL PATHWAYS
One may argue that children are unlikely to be sensitive to a policy
change primarily aimed at reducing SHS exposure in public
places such as the workplace, bars and restaurants. Findings from
several studies, however, provide support for a number of
pathways underlying a potential causal link between smoke-free
legislation and improved child health. We have summarised these
in a directed acyclic graph (Figure 2), and we discuss the
supporting evidence below, by timing of tobacco smoke exposure:
antenatal versus postnatal.
Maternal smoking, SHS exposure and adverse pregnancy
outcomes
When a pregnant woman smokes or is exposed to SHS, many
constituents of tobacco smoke readily cross the placenta and
expose the developing fetus to the associated health risks.25
Active maternal smoking during pregnancy is a recognised risk
factor for a variety of adverse pregnancy outcomes, including
stillbirth,7 low birthweight,1 preterm birth,26 small for gestational
age (SGA) birth,27 congenital anomalies28 and neonatal mortality.1
It is, in addition, associated with adverse health outcomes
during childhood, including SIDS,14 wheezing/asthma29,30 and
RTIs (Table 1).32 Smoking cessation during pregnancy has been
shown to normalise many of these risks.34–36
Similar to active smoking, SHS exposure during pregnancy is
associated with increased risks of stillbirth,8 low birthweight,9
congenital anomalies8 and development of childhood wheezing/
asthma (Table 1).30 Although very few studies have evaluated the
effectiveness of interventions to reduce SHS exposure during
pregnancy,37 it appears that such interventions have the potential
to improve birth outcomes, which include reducing the incidence
of very low birthweight and very preterm birth.38 This suggests
that, similar to the perinatal health risks associated with active
smoking during pregnancy, those related to SHS exposure are
indeed avoidable.
Smoke-free legislation and maternal smoking and SHS exposure
A number of studies support a link between the implementation
of smoke-free laws and a reduction in maternal smoking during
pregnancy.39–44 In Scotland, for example, the prevalence of
maternal smoking during pregnancy decreased from 25.4
to 18.8% (Po0.001) after the 2006 implementation of
comprehensive legislation prohibiting smoking in public
places.42 Improved perinatal outcomes, namely decrease in low
birthweight and preterm delivery, were found among both
women who smoked and those who did not smoke during
pregnancy.42 This suggests that reductions in both active smoking
and SHS exposure during pregnancy contribute to the observed
MPOWER measures 
Monitor tobacco use and prevenon policies 
Protect people from tobacco use 
Offer help to quit tobacco use 
Warn about the dangers of tobacco 
Enforce bans on tobacco adversing, promoon and sponsorship
Raise taxes on tobacco 
Figure 1. MPOWER measures. MPOWER is an acronym of the six
categories of tobacco control measures recommended by the World
Health Organisation to combat the death and disease burden
caused by smoking and exposure to second-hand smoke.
Source: WHO report on the global tobacco epidemic, 2015: raising
taxes on tobacco.2
Second-hand
smoke exposure
Social norm
changes
Smoking cessaon 
and iniaon
Smoke-free
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Smoking during 
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Figure 2. Likely causal pathways between smoke-free legislation and perinatal and paediatric health outcomes. Source: Adapted from
Peelen et al.24
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drop in adverse perinatal outcomes sensitive to tobacco
smoke.41,42,45
Although we are unaware of studies assessing the association
between smoke-free legislation and SHS exposure during
pregnancy specifically, significant reductions in SHS exposure
among the general adult population were observed in the
majority of studies on the topic.16,18 Much of this effect is likely
owing to the actual smoking restrictions in public places.
Many studies have, in addition, demonstrated a drop in
smoking initiation among the youth,17,46 a drop in overall smoking
prevalence and cigarette consumption and an increase in smoking
cessation after the introduction of smoke-free legislation, likely
contributing to the overall reduction in SHS exposure (Figure 2).16
SHS exposure and child health
Children’s exposure to SHS is associated with SIDS,14 wheezing/
asthma,29,30,47 RTIs,32 otitis media with effusion48 and
meningococcal disease.13 (Table 2) These risks have been shown
to be independent of those associated with maternal smoking
during pregnancy.14,30,32,48
Smoke-free legislation and childhood SHS exposure
Smoke-free legislation has been associated with reductions in SHS
exposure among children in various countries.49–52 Although
smoke-free legislation is primarily aimed at reducing SHS exposure
in public places, the primary location for children to be exposed is
the home environment.53,54 In this context, it is important to note
that, in addition to reducing SHS exposure in public places,
implementation of smoke-free legislation is also associated with
reductions in smoking at home and with increased adoption of
home-smoking bans.53–57 This illustrates how, through norm
spreading, smoke-free legislation may carry additional benefits
mediated via reducing SHS exposure beyond locations primarily
targeted.
SMOKE-FREE LEGISLATION AND EARLY-LIFE HEALTH
OUTCOMES
Through the previously described changes in maternal
smoking and antenatal and postnatal SHS exposure after the
implementation of smoke-free legislation, one might expect to
also observe changes in smoking- and SHS-associated
perinatal and paediatric health outcomes. Below we
discuss evidence from studies assessing the link
between smoke-free legislation and perinatal and child health
(summarised in Table 3).
Perinatal health outcomes
Perinatal mortality. Consistent with the recognised link between
antenatal smoke exposure and perinatal mortality, the
introduction of a comprehensive smoke-free law in England was
associated with an immediate − 7.8% (95% confidence interval
(95% CI): − 11.8 to − 3.5) reduction in stillbirths and a − 7.6%
(−11.7 to − 3.4) reduction in neonatal deaths.45 We estimated that,
per year, over 240 stillbirths and more than 100 neonatal deaths
have been averted across England since the implementation of
the legislation.45 In a smaller study in the Netherlands, we did
not observe a significant association between phased introduction
of smoke-free legislation, introduced in conjunction with other
tobacco control policies, and perinatal mortality.24 We speculated
that lack of enforcement and lower compliance compared with
that in England may have attenuated the impact of smoke-free
legislation on these outcomes in the Netherlands.63–67 Other
factors including methodological and population differences may
also have contributed to the discrepant findings, and additional
studies are needed to investigate the impact of comprehensive
smoke-free legislation on perinatal mortality.
Low birthweight. In a systematic review published in 2014,58
we identified six studies assessing the association between
smoke-free legislation and low birthweight.41,42,44,68–70 One study
demonstrated an immediate reduction in low birthweight,42
whereas another showed a gradual reduction.70 In a meta-
analysis combining all six studies, however, neither the immediate
nor the gradual reduction was statistically significant.58 Follow-on
studies also show mixed evidence.24,40,45,59,71,72 A closer look at
this evidence suggests that reductions in low birthweight are
generally observed in countries with the most comprehensive
laws.40,42,45,59
Table 1. Selected child health outcomes associated with antenatal
tobacco smoke exposure
Outcome Effect size (95% CI)
Maternal smoking during pregnancy
Perinatal outcomes
Stillbirth 1.4 (1.27–1.46); ref. 7
Preterm birth 1.27 (1.21–1.33); ref. 26
Birth defects (gastrointestinal) 1.27 (1.18–1.35); ref. 28
Birth defects (cardiovascular) 1.09 (1.02–1.17); ref. 28
Birth defects (musculoskeletal) 1.16 (1.05–1.27); ref. 28
Birth defects (central nervous system) 1.10 (1.01–1.19); ref. 28
Childhood outcomes
Sudden infant death syndrome 2.25 (2.03–2.50); ref. 14
Early wheezing (age ⩽ 2 years) 1.33 (1.03–1.71); ref. 30
Recurrent wheezing 1.49 (1.33–1.67); ref. 31
Wheezing/asthma in ⩾ 6-year-olds 1.22 (1.03–1.44); ref. 29
Lower respiratory infections 1.24 (1.11–1.38); ref. 32
Overweight 1.33 (1.23–1.44); ref. 33
Obesity 1.60 (1.37–1.88); ref. 33
Maternal second-hand smoke exposure during pregnancy
Perinatal outcomes
Stillbirth 1.23 (1.09–1.38); ref. 8
Low birthweight 1.32 (1.07–1.63); ref. 9
Birth defects 1.13 (1.01–1.26); ref. 8
Childhood outcomes
Early wheezing (age ⩽ 2 years) 1.11 (1.03–1.20); ref. 30
Outcomes with positive associations demonstrated in meta-analyses
are shown.
Abbreviation: CI, confidence interval.
Table 2. Selected child health outcomes associated with postnatal
tobacco smoke exposure
Outcome Effect size (95% CI)
Sudden infant death syndrome 1.97 (1.77–2.19); ref. 14
Early wheezing (age ⩽ 2 years) 1.29 (1.19–1.40); ref. 30
Wheezing/asthma in ⩾ 6-year-olds 1.30 (1.13–1.51); ref. 29
Hospitalisation for asthma
exacerbation
1.85 (1.20–2.86); ref. 47
Lower respiratory infections 1.54 (1.40–1.69); ref. 32
Middle ear infection (including otitis
media with effusion)
1.32 (1.20–1.45); ref. 48
Meningococcal disease 2.02 (1.52–2.69); ref. 13
Outcomes with positive associations demonstrated in meta-analyses
are shown.
Abbreviation: CI, confidence interval.
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Low birthweight is usually the result of either short gestation
(preterm birth) or fetal growth restriction (SGA), and a number of
studies have evaluated the association between smoke-free
legislation and these outcomes.
Preterm birth. In our systematic review on smoke-free legislation
and child health, we identified four studies investigating the
association with preterm birth.41,42,44,69 Three demonstrated a
statistically significant decrease in preterm birth,42,44,69 resulting in a
pooled reduction of − 10.4% (95% CI: − 18.8 to − 2.0) in meta-
analysis.58 The association between smoke-free legislation and a
drop in preterm birth was later confirmed in Quebec.59 A recent
Swiss study provided evidence of a ‘dose–response’ relationship,
with the largest reductions in preterm births observed among
pregnancies that were fully protected by smoke-free legislation
(versus only from the second or third trimester) and in areas with
the most comprehensive legislation.73 Furthermore, a reduction in
very preterm births was observed following extension of the
smoke-free workplace law in the Netherlands to include hospitality
venues.24 On the other hand, two large evaluations of local US
smoke-free laws failed to demonstrate a link between smoke-free
laws and preterm birth.71,72 A systematic and comprehensive
assessment of the strengths and weaknesses of these studies, and
the coverage and enforcement of and compliance with the
legislation in relation to the reported effect sizes, is ongoing and
will help to better understand the discrepant findings.74
Small for gestational age. Being SGA is a more specific indicator
of intrauterine growth restriction than is low birthweight, as it
takes into account the gestational age of the baby. Several studies
support a link between smoke-free legislation and a reduction in
the risk of babies being born SGA. In a meta-analysis of three
studies, although the overall reduction in SGA babies was not
statistically significant (−1.40%, 95% CI: − 3.20 to 0.40), the number
of very SGA babies dropped by − 5.30% (95% CI: − 5.42
to − 5.18).58 Follow-on work conducted in Quebec and the
Netherlands also showed significant reductions in the risk for
SGA birth following smoke-free legislation.24,59 Again, this was
mainly owing to a reduction in very SGA births.24
Child health outcomes
Infant mortality. In our analysis of the smoke-free law in England,
we observed an immediate reduction in infant mortality (−6.3%,
95% CI: − 9.6 to − 2.9) following its implementation.45 This was
mainly attributable to the reduction in neonatal deaths described
earlier.45 Despite the strong epidemiological link between SHS
exposure and SIDS, we did not, however, observe a significant
change in the odds of SIDS in this study. Although an ecological
study in the United States did demonstrate an association
between strong smoke-free policies and reduced SIDS
incidence,75 this was not confirmed in a multi-country analysis
conducted by the same researchers.76 Thus, although smoke-free
legislation appears to be associated with an overall reduction in
infant mortality,45 this cannot be attributed to a reduction in SIDS.
Asthma. Asthma remains the most common chronic disease in
childhood,77 and childhood asthma is linked to the development
of long-term reduced lung function and chronic obstructive
pulmonary disease.78 Consistent evidence supports an association
Table 3. Association between smoke-free legislation and changes in child health outcomes
Outcome Effect size (95% CI) Study type Location(s) Legislation
comprehensive?
Perinatal outcomes
Stillbirth − 7.8% (−11.8 to − 3.5); ref. 45 ITS England Yes
− 1% (−9 to 8)/− 3% (−12 to 6); ref. 24 ITS Netherlands No
Low birthweight − 1.7% (−5.1 to 1.6); ref. 58 MA Belgium, Norway,
Scotland, USA
Mixed
Very low birthweight − 35.4% (−111.1 to 40.3); ref. 58 MA Norway, USA No
Preterm birth − 10.4% (−18.8 to − 2.0); ref. 58 MA Belgium, Norway,
Scotland, USA
Mixed
Very preterm birth − 17.4% (−26.9 to − 6.7); ref. 42 ITS Scotland Yes
− 2.3%a (−3.7 to − 0.9); ref. 59 ITS Quebec, Canada Yes
− 6% (−14 to 3)/− 11% (−19 to − 3); ref. 24 ITS Netherlands No
SGA − 1.4% (−3.2 to 0.4); ref. 58 MA Belgium, Ireland,
Scotland
Mixed
Very SGA − 5.3% (−5.4 to − 5.2); ref. 58 MA Ireland, Scotland Yes
Congenital anomalies 1% (−6 to 8)/− 2% (−9 to 6); ref. 24 ITS Netherlands No
− 0.03%a (−4.0 to 3.9); ref. 41 CITS Norway No
Neonatal mortality − 7.6% (−11.7 to − 3.4); ref. 45 ITS England Yes
− 3% (−16 to 12)/− 12% (−24 to 2); ref. 24 ITS Netherlands No
Childhood outcomes
Infant mortality − 6.3% (−9.6 to − 2.9); ref. 45 ITS England Yes
Sudden infant death syndrome 1.8% (−8.4 to 13.2); ref. 45 ITS England Yes
Asthma hospital attendance − 10.1% (−15.2 to − 5.0); ref. 58 MA Canada, England, USA Mixed
RTI hospital admissions − 3.5% (−4.5 to − 2.3); ref. 60 ITS England Yes
Lower RTI hospital admissions − 13.8% (−15.6 to − 12.0); ref. 60 ITS England Yes
− 33.5% (−36.4 to − 30.5); ref. 61 ITS Hong Kong Yes
Lower RTI emergency
department visits
− 8% (−13 to −4%); ref. 62 CITS USA Mixed
For each outcome, findings from meta-analysis are shown where available; findings from individual studies are shown otherwise. For the study conducted in
the Netherlands, figures represent the impact of smoke-free legislation in the workplace, and extension to bars and restaurants, respectively.
Abbreviations: CI, confidence interval; CITS, interrupted time series with control group; ITS, interrupted time series; MA, meta-analysis; RTI, respiratory tract
infection; SGA, small for gestational age.
aAbsolute change (percentage points).
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between smoke-free legislation and a reduction in childhood
hospital attendance for asthma exacerbations. In our systematic
review, we identified four studies evaluating this link.79–82 In a
meta-analysis, the implementation of smoke-free legislation was
associated with a − 10.1% (95% CI: − 15.2 to − 5.0) decrease in
paediatric emergency department visits and hospital admissions
for asthma.58 This association was confirmed in later studies
conducted in the United States,62,83,84 and is in line with
meta-analyses of adult studies demonstrating a link between
smoke-free legislation and a reduction in severe respiratory
events (i.e., deaths or hospital admissions).19 Other studies show
that smoke-free policies do not affect overall asthma incidence
among children, suggesting that the observed reductions in
hospital attendance are indeed the result of a drop in asthma
exacerbations.85,86
Respiratory tract infections. RTIs account for the majority of the
disease burden associated with SHS exposure among children.6 In
our 2014 systematic review, we did not, however, identify
any studies that investigated the association between the
implementation of smoke-free legislation and RTIs.58 We
addressed this in an evaluation of the 2007 comprehensive
smoke-free law in England, using data of over 1.6 million
paediatric hospital admissions for RTIs over a 12-year period.
There was an immediate − 3.5% (95% CI: − 4.7 to − 2.3) decrease in
RTI admissions, which was mainly attributable to a reduction in
lower RTI admissions (−13.8% (95% CI: − 15.6 to − 12.0)).60 This
translated into an estimated ~11,000 paediatric RTI hospital
admissions being averted per year during the first 5 years
following the implementation of smoke-free legislation. This link
between smoke-free legislation and a reduction in hospital
attendance for paediatric lower RTIs was recently confirmed in
an evaluation of the 2007 comprehensive smoke-free law in Hong
Kong,61 and a multi-state analysis in the United States.62 Similar to
the studies on asthma, although hospital admissions for RTIs went
down after smoke-free legislation,60–62 there did not appear to
have been an overall reduction in RTI incidence.85 The observed
drops in RTI hospitalisations are therefore more likely to represent
reductions in disease severity rather than incidence, consistent
with epidemiological evidence identifying SHS as a risk factor for
severe RTI presentations among children.87,88
Smoke-free legislation and health inequalities
Tobacco smoking and SHS exposure are important drivers of
socio-economic disparities in health outcomes and life
expectancy. There are concerns regarding the potential for certain
tobacco control policies to have a negative equity impact.89 In
England, the reduction in paediatric RTI admissions following the
smoke-free law was largest among children from deprived areas,
suggesting that a pro-equity effect may be present.60 There was,
however, no differential association between smoke-free
legislation and child health according to socio-economic status
in other studies having evaluated this.59,72,80
INTERPRETING THE EVIDENCE
Clearly over recent years, the evidence base assessing the
potential links between smoke-free legislation and population
health, including that of children, has grown substantially.
Interpretation of the totality of evidence is, however, complicated
not only by the fact that it is derived from quasi-experimental
evaluations but also by the range of additional potential sources
of variation between studies. Examples include geographical
location, population demographics, comprehensiveness and
enforcement of the legislation, public support for and compliance
with the law, degree of associated social norm spreading and
methodological aspects of the studies, including choice of
statistical models and approaches to handling sources of bias
and potential confounding. Such factors may have contributed to
some of the observed inconsistencies between findings of
individual studies. Meta-epidemiological evaluations of studies
assessing health outcomes following smoke-free legislation
among adults have already allowed some of this variation to be
taken into account when interpreting the evidence.19 With the
number of studies in the paediatric field continuing to increase,
similar opportunities now open up to further increase confidence
in the conclusions made according to these studies.74
IMPLICATIONS FOR POLICY AND PRACTICE
Despite the limitations of the existing evidence base, it provides
considerable support for a link between smoke-free legislation
and improved perinatal and child health outcomes. Reductions in
maternal smoking during pregnancy and in SHS exposure during
pregnancy and childhood are likely to be the main drivers behind
the observed reductions in adverse early-life health outcomes
(Figure 2). The observed associations are in line with the
recognised causal links between prenatal and childhood tobacco
smoke exposure and adverse perinatal and paediatric health
outcomes, as well as the already recognised substantial popula-
tion health effects of smoke-free policies among adults.16,18,19,58
Improved compliance with WHO guidelines to address the
ongoing global tobacco epidemic and reduce its associated
substantial burden of death and disease is clearly needed so that
more and more (unborn) children as well as adults can enjoy these
health benefits. Over 80% of the world’s population, however,
currently remains unprotected by comprehensive smoke-free
laws, and global compliance with other MPOWER policies is
smaller still.2 Smoke-free laws are generally well supported by
the public and appear highly cost-effective.90,91 It is crucial for
policymakers to realise that such policies are most effective in
reducing SHS exposure and improving population health
when implemented in a comprehensive manner (i.e., covering
both workplaces and the hospitality industry).19,40,92 Smoke-free
laws should ideally be part of an integrated tobacco endgame
strategy in which, among other aspects, tobacco tax increase
is an important element.93 Tobacco taxes are considered the most
effective measure to reduce tobacco use,2 and have
been demonstrated to also benefit perinatal and infant
health via reductions in maternal smoking rates during
pregnancy.39,72,76,94,95
Protecting (unborn) children from the adverse impact of
tobacco smoking and SHS exposure should be a key priority for
policymakers and health workers alike. Health practitioners have a
responsibility to discuss the dangers of active smoking and
second- and third-hand smoke exposure (i.e., exposure to toxic
tobacco constituents via clothing, curtains, carpets, etc.) in relation
to children’s health with relevant family members and
pre-conceptional and pregnant women. They should be aware
of the existing local care pathways to support smoking cessation
and be ready to offer cessation advice and pharmacological
support when necessary.
KNOWLEDGE GAPS AND FUTURE RESEARCH
Now that several health benefits of comprehensive legislation to
prohibit smoking in indoor public places have been established,
there is a need to evaluate the effectiveness of reducing SHS
exposure in other places. An increasing number of countries are
now implementing laws to protect children from SHS in outdoor
areas (e.g., playgrounds, school grounds, parks, beaches) and
private environments, such as cars.2,96–99 There is a need to
evaluate the effectiveness of such policies in reducing SHS
exposure, denormalising smoking and improving child health to
inform policymakers in other countries that may be considering
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implementing similar legislation. There is furthermore a need to
identify the effectiveness of additional policy strategies, such as
tobacco taxes and mass media campaigns, and combinations of
such policies to, in particular, improve child health and reduce
smoking initiation among children. Ongoing work to collate
existing studies on tobacco control policies and child health via a
systematic review will help provide a comprehensive assessment
of the available evidence on this topic.74 Given the shifting
burden of smoking and tobacco-related death and disease from
high-income to low- and middle-income countries, there is a
particular need to assess the impact of tobacco control strategies
in such countries and develop tools to support their policymakers
in prioritising the most effective policies to improve population
health.58 In parallel to such policy-based evaluations, researchers
should continue to develop, evaluate and help implement
strategies and interventions to prevent SHS exposure among
children at the individual, family and community level.
Conclusions
Evidence suggests that comprehensive smoke-free legislation is
associated with reductions in perinatal mortality, preterm birth
and paediatric hospital admissions for RTIs and asthma.45,58,60,61
There is a clear need for wider implementation of comprehensive
smoke-free policies across the globe as a key constituent
of tobacco endgame strategies in accordance with FCTC
recommendations to improve the population health of (unborn)
children and adults alike.2
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